Aleve PM Enters Nighttime Pain-Relief Market After 160-Count Label Approved
This article was originally published in The Tan Sheet
Executive Summary
Bayer HealthCare business on Sept. 15 announced the product with 220mg naproxen sodium and 25mg diphenhydramine HCL is available at U.S. retailers. Its NDA was approved in January, but Bayer waited for FDA’s OK on 160-count labeling before launching the product.